| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF03189516 |
| P698 | PubMed publication ID | 7250152 |
| P2093 | author name string | J Heykants | |
| M Michiels | |||
| H Scheygrond | |||
| W Meuldermans | |||
| R Hendriks | |||
| H Reyntjens | |||
| P2860 | cites work | Influence of route of administration on drug availability | Q34226637 |
| A double-blind crossover trial of domperidone in chronic postprandial dyspepsia | Q39576958 | ||
| A double-blind study of domperidone in the symptomatic treatment of chronic post-prandial upper gastrointestinal distress | Q41087250 | ||
| Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying | Q41087266 | ||
| Domperidone for the symptomatic treatment of chronic post-prandial nausea and vomiting | Q41087274 | ||
| A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children | Q41087282 | ||
| A multicentre pilot study of parenteral and rectal administration of domperidone in the treatment of severe vomiting in children | Q41087300 | ||
| Domperidone in the prevention of post-operative nausea and vomiting | Q41087309 | ||
| Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry | Q41087326 | ||
| Effect of domperidone on gastric emptying and secretion | Q41756509 | ||
| The effect of domperidone on pyloric activity in dog and in man | Q41756513 | ||
| On the pharmacokinetics of domperidone in animals and man III. Comparative study on the excretion and metabolism of domperidone in rats, dogs and man. | Q42257519 | ||
| The plasma protein binding and distribution of etomidate in dog, rat and human blood | Q44558000 | ||
| Domperidone, a novel and safe gastrokinetic anti-nauseant for the treatment of dyspepsia and vomiting | Q46537642 | ||
| The antiemetic effects of domperidone, a novel potent gastrokinetic. | Q52298980 | ||
| Domperidone as an anti-emetic; summary of research reports | Q66895751 | ||
| Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity | Q66955073 | ||
| 3H-Domperidone: A selective ligand for dopamine receptors | Q66966261 | ||
| Inhibition of dopamine receptors in the stomach: an explanation of the gastrokinetic properties of domperidone | Q67381286 | ||
| Pentazocine binding to blood cells and plasma proteins | Q68794088 | ||
| On the pharmacokinetics of domperidone in animals and man. I. Plasma levels of domperidone in rats and dogs. Age related absorption and passage through the blood brain barrier in rats | Q70825471 | ||
| On the pharmacokinetics of domperidone in animals and man II. Tissue distribution, placental and milk transfer of domperidone in the Wistar rat | Q70825476 | ||
| P433 | issue | 1 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| bioavailability | Q461809 | ||
| P304 | page(s) | 61-70 | |
| P577 | publication date | 1981-01-01 | |
| P1433 | published in | European Journal of Drug Metabolism and Pharmacokinetics | Q15757261 |
| P1476 | title | On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration | |
| P478 | volume | 6 |
| Q93094434 | A Pediatric Covariate Function for CYP3A-Mediated Midazolam Clearance Can Scale Clearance of Selected CYP3A Substrates in Children |
| Q52003016 | Bioavailability prediction based on molecular structure for a diverse series of drugs. |
| Q35965791 | Biowaivers for oral immediate-release products: implications of linear pharmacokinetics |
| Q50019963 | Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias. |
| Q24301858 | Characterization of human cytochrome P450 enzymes catalyzing domperidone N-dealkylation and hydroxylation in vitro |
| Q37944771 | Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II). |
| Q78099509 | Determination of domperidone in human serum and human breast milk by high-performance liquid chromatography-electrospray mass spectrometry |
| Q30582295 | Disruption of aminergic signalling reveals novel compounds with distinct inhibitory effects on mosquito reproduction, locomotor function and survival |
| Q24561511 | Domperidone for lactating women |
| Q40248870 | Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic |
| Q77428141 | Domperidone. A review of its use in diabetic gastropathy |
| Q28350699 | Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial |
| Q74311370 | High-performance liquid chromatographic analysis for the determination of domperidone in human plasma |
| Q34116212 | Interaction Between Domperidone and Ketoconazole: Toward Prediction of Consequent QTc Prolongation Using Purely In Vitro Information |
| Q43205141 | Interactions between domperidone and ropinirole, a novel dopamine D2-receptor agonist |
| Q34261356 | Itraconazole and domperidone: a placebo-controlled drug interaction study |
| Q70212946 | Metoclopramide, domperidone and dopamine in man: actions and interactions |
| Q70825476 | On the pharmacokinetics of domperidone in animals and man II. Tissue distribution, placental and milk transfer of domperidone in the Wistar rat |
| Q42257519 | On the pharmacokinetics of domperidone in animals and man III. Comparative study on the excretion and metabolism of domperidone in rats, dogs and man. |
| Q70825471 | On the pharmacokinetics of domperidone in animals and man. I. Plasma levels of domperidone in rats and dogs. Age related absorption and passage through the blood brain barrier in rats |
| Q24608623 | Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study |
| Q41445264 | Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease |
| Q39810434 | Pharmacokinetics and comparative bioavailability of domperidone suspension and tablet formulations in healthy adult subjects |
| Q26860602 | Pharmacological overview of galactogogues |
| Q24649687 | Predicting new molecular targets for known drugs |
| Q62566944 | Prediction of drug bioavailability based on molecular structure |
| Q34783396 | Quantitation of small intestinal permeability during normal human drug absorption |
| Q77804414 | Quantitative determination of domperidone in rat plasma by high-performance liquid chromatography with fluorescence detection |
| Q43985923 | Rapid and sensitive liquid chromatography-tandem mass spectrometry method for the quantitation of domperidone in human plasma |
| Q46518394 | Short-term effect of domperidone on gastroesophageal reflux in newborns assessed by combined intraluminal impedance and pH monitoring. |
| Q24635649 | Treating nausea and vomiting in palliative care: a review |
| Q37354119 | Treatment of nausea and vomiting in terminally ill cancer patients. |
Search more.